Objective: The efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in reducing cardiovascular outcomes in patients with diabetes and overt nephropathy is still a controversial issue. Forest plot for evaluation of publication bias for cardiovascular outcomes. Discussion The presence of kidney disease is associated with a markedly elevated risk of CVD and death in… Continue reading Objective: The efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers